FI813177L - 2-gyanidino-4-heteroaryltiazoler - Google Patents

2-gyanidino-4-heteroaryltiazoler

Info

Publication number
FI813177L
FI813177L FI813177A FI813177A FI813177L FI 813177 L FI813177 L FI 813177L FI 813177 A FI813177 A FI 813177A FI 813177 A FI813177 A FI 813177A FI 813177 L FI813177 L FI 813177L
Authority
FI
Finland
Prior art keywords
heteroaryltiazoler
gyanidino
Prior art date
Application number
FI813177A
Other languages
English (en)
Other versions
FI75821C (fi
FI75821B (fi
Inventor
John Lawrence Lamatthina
Christopher Andrew Lipinski
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of FI813177L publication Critical patent/FI813177L/fi
Application granted granted Critical
Publication of FI75821B publication Critical patent/FI75821B/fi
Publication of FI75821C publication Critical patent/FI75821C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • C07C45/70—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • C07C45/70—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form
    • C07C45/71—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form being hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/44—Acylated amino or imino radicals
    • C07D277/48—Acylated amino or imino radicals by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof, e.g. carbonylguanidines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
FI813177A 1980-10-14 1981-10-13 Foerfarande foer framstaellning av terapeutiskt aktiva 2-guanidino-4-heteroaryltiazoler. FI75821C (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US19623180A 1980-10-14 1980-10-14
US19623180 1980-10-14
US29357481 1981-08-20
US06/293,574 US4374843A (en) 1980-10-14 1981-08-20 2-Guanidino-4-heteroarylthiazoles

Publications (3)

Publication Number Publication Date
FI813177L true FI813177L (fi) 1982-04-15
FI75821B FI75821B (fi) 1988-04-29
FI75821C FI75821C (fi) 1988-08-08

Family

ID=26891753

Family Applications (1)

Application Number Title Priority Date Filing Date
FI813177A FI75821C (fi) 1980-10-14 1981-10-13 Foerfarande foer framstaellning av terapeutiskt aktiva 2-guanidino-4-heteroaryltiazoler.

Country Status (28)

Country Link
US (1) US4374843A (fi)
EP (1) EP0050458B1 (fi)
KR (1) KR850001858B1 (fi)
AR (3) AR228674A1 (fi)
AT (1) ATE11048T1 (fi)
AU (2) AU530589B2 (fi)
CA (1) CA1156239A (fi)
CS (1) CS231182B2 (fi)
DD (4) DD202293A5 (fi)
DE (1) DE3168067D1 (fi)
DK (1) DK453181A (fi)
ES (4) ES506216A0 (fi)
FI (1) FI75821C (fi)
GR (1) GR75098B (fi)
HK (1) HK52387A (fi)
HU (2) HU191895B (fi)
IE (1) IE51642B1 (fi)
IL (1) IL64035A (fi)
KE (1) KE3707A (fi)
MY (1) MY8700512A (fi)
NO (1) NO159654C (fi)
NZ (1) NZ198629A (fi)
PH (3) PH17562A (fi)
PL (3) PL133712B1 (fi)
PT (1) PT73817B (fi)
SG (1) SG23487G (fi)
SU (1) SU1153829A3 (fi)
YU (4) YU42434B (fi)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4482723A (en) * 1983-04-11 1984-11-13 Pfizer Inc. Process for preparation of 4-acetyl-2-substituted-imidazoles
US4435396A (en) 1982-05-10 1984-03-06 Pfizer Inc. Antiulcer 2-guanidino-4-(2-substituted-amino-4-imidazolyl)thiazoles and process therefor
GB2122988B (en) * 1982-06-17 1986-06-11 Toyama Chemical Co Ltd Process for producing 2-(2-aminothiazol-4-yl) glyoxylic acid derivative; intermediates
EP0156644A1 (en) * 1984-04-02 1985-10-02 Pfizer Inc. Process and intermediates for 4-acetylimidazoles
US4560690A (en) * 1984-04-30 1985-12-24 Pfizer Inc. 2-(N-substituted guanidino)-4-hetero-arylthiazole antiulcer agents
US4632993A (en) * 1984-10-11 1986-12-30 Pfizer Inc. Process for making 2-guanidino-4-(2-methyl-4-imidazolyl) thiazole dihydrobromide
US4567179A (en) * 1984-10-11 1986-01-28 Pfizer, Inc. Antiinflammatory salts of piroxicam
US4591595A (en) * 1984-10-11 1986-05-27 Pfizer Inc. 2-guanidino-4-(2-methyl-4-imidazolyl)thiazoles in the treatment of rheumatoid arthritis
WO1986003203A1 (en) * 1984-11-22 1986-06-05 Yoshitomi Pharmaceutical Industries, Ltd. Thienylthiazole derivatives
US4814341A (en) * 1986-08-26 1989-03-21 Reiter Lawrence A 2-guanidino-4-(2-furyl) thiazoles as antiulcer agents
ES2031514T3 (es) * 1986-08-29 1992-12-16 Pfizer Inc. 2-guanidino-4-ariltiazoles para el tratamiento de ulceras pepticas.
ATE106884T1 (de) * 1986-10-29 1994-06-15 Pfizer Verfahren zur herstellung von 2-(1-pentyl-3- guanidino)-4-(2-methyl-4-imidazolyl)thiazol und dessen kristallinisches dihydrochlorid-trihydrat.
IL95548A0 (en) * 1989-09-15 1991-06-30 Fujisawa Pharmaceutical Co Thiazole derivatives,processes for the preparation thereof and pharmaceutical composition containing the same
WO1992016526A1 (en) * 1991-03-13 1992-10-01 Fujisawa Pharmaceutical Co., Ltd. Thiazole derivatives
SI0928793T1 (en) * 1998-01-02 2002-10-31 F. Hoffmann-La Roche Ag Thiazole derivatives
CA2619731A1 (en) * 2005-08-23 2007-03-01 Ube Industries, Ltd. Process for preparing 1-substituted 5-acylimidazole compounds
US9499533B2 (en) 2012-03-27 2016-11-22 Shionogi & Co., Ltd. Aromatic 5-membered heterocyclic derivative having TRPV4-Inhibiting activity
EP4196793A1 (en) 2020-08-11 2023-06-21 Université de Strasbourg H2 blockers targeting liver macrophages for the prevention and treatment of liver disease and cancer

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1516777A (fr) * 1966-08-02 1968-02-05 Innothera Lab Sa Dérivés du thiazole ainsi que de la thiazolo [4,5-d] pyridazine et leur préparation
US3519637A (en) * 1966-12-06 1970-07-07 Hoffmann La Roche 1-(4-thiazolylmethyl)nitroimidazole derivatives
BE758146A (fr) * 1969-10-29 1971-04-28 Smith Kline French Lab Derives de l'amidine
US3950353A (en) * 1971-03-09 1976-04-13 Smith Kline & French Laboratories Limited Pharmacologically active thiourea and urea compounds
HU168776B (fi) * 1973-11-09 1976-07-28
DE2614189A1 (de) * 1976-04-02 1977-10-20 Hoechst Ag Therapeutisch wirksame ureido- und semicarbazido-derivate des tiazols und verfahren zu ihrer herstellung
NZ186965A (en) * 1977-04-20 1980-02-21 Ici Ltd Guanidino derivatives and pharmaceutical compositions
JPS54132566A (en) * 1978-01-18 1979-10-15 Ici Ltd Guanidine derivative*its manufacture and secretion controlling pharmaceutical composition containing it
DE3069889D1 (en) * 1979-01-18 1985-02-14 Ici Plc Guanidine derivatives, processes for their manufacture and pharmaceutical compositions containing them
US4220654A (en) * 1979-06-04 1980-09-02 Merck & Co., Inc. Cyclic imidazole cyanoguanidines
AU518569B2 (en) * 1979-08-07 1981-10-08 Farmos-Yhtyma Oy 4-benzyl- and 4-benzoyl imidazole derivatives

Also Published As

Publication number Publication date
PL134491B1 (en) 1985-08-31
SU1153829A3 (ru) 1985-04-30
HU186788B (en) 1985-09-30
AR228674A1 (es) 1983-03-30
PT73817A (en) 1981-11-01
YU42434B (en) 1988-08-31
AU7628781A (en) 1982-04-22
AU3206284A (en) 1984-11-29
PL241643A1 (en) 1983-11-21
MY8700512A (en) 1987-12-31
ATE11048T1 (de) 1985-01-15
AR228675A1 (es) 1983-03-30
AU548992B2 (en) 1986-01-09
YU42076B (en) 1988-04-30
YU42077B (en) 1988-04-30
IL64035A (en) 1986-01-31
IE812384L (en) 1982-04-14
ES8306750A1 (es) 1983-06-01
ES8301978A1 (es) 1982-12-16
DD207913A5 (de) 1984-03-21
YU105383A (en) 1983-10-31
PL135331B1 (en) 1985-10-31
DE3168067D1 (en) 1985-02-14
PL241644A1 (en) 1983-11-21
ES506216A0 (es) 1982-12-16
GR75098B (fi) 1984-07-13
CA1156239A (en) 1983-11-01
EP0050458A2 (en) 1982-04-28
AR229703A1 (es) 1983-10-31
DD207718A5 (de) 1984-03-14
US4374843A (en) 1983-02-22
SG23487G (en) 1987-07-10
IL64035A0 (en) 1982-01-31
EP0050458A3 (en) 1982-09-01
DK453181A (da) 1982-04-15
FI75821C (fi) 1988-08-08
PL233430A1 (en) 1983-11-21
KR830007638A (ko) 1983-11-04
PH17562A (en) 1984-10-01
PL133712B1 (en) 1985-06-29
NO159654B (no) 1988-10-17
ES8306749A1 (es) 1983-06-01
CS750081A2 (en) 1984-02-13
DD202293A5 (de) 1983-09-07
HU191895B (en) 1987-04-28
KR850001858B1 (ko) 1985-12-28
YU42078B (en) 1988-04-30
FI75821B (fi) 1988-04-29
ES8306751A1 (es) 1983-06-01
CS231182B2 (en) 1984-10-15
AU530589B2 (en) 1983-07-21
YU105183A (en) 1983-10-31
HK52387A (en) 1987-07-17
NO813442L (no) 1982-04-15
NZ198629A (en) 1985-02-28
PT73817B (en) 1983-11-07
ES515159A0 (es) 1983-06-01
YU105283A (en) 1983-10-31
DD207719A5 (de) 1984-03-14
ES515157A0 (es) 1983-06-01
YU246481A (en) 1983-10-31
KE3707A (en) 1987-04-03
NO159654C (no) 1989-01-25
PH17856A (en) 1985-01-09
PH18467A (en) 1985-07-18
IE51642B1 (en) 1987-01-21
EP0050458B1 (en) 1985-01-02
ES515158A0 (es) 1983-06-01

Similar Documents

Publication Publication Date Title
BE887534A (fr) Sandwichpaneelelement
BE889577A (nl) Golfvormsynthese
BE891422A (fr) Degrilleur
BR8107326A (pt) Container-tanque
FI813177L (fi) 2-gyanidino-4-heteroaryltiazoler
BR8101718A (pt) Microcentrais
BE889004A (nl) Grijper
BE889192A (fr) Recolteuse-hacheuse
BR8108640A (pt) Filatorio
DE3163961D1 (de) Heteroalkylene-bis-anthraquinones
FI803782L (fi) Laminatvax avsett foer foerpackningslaminat
BR8108621A (pt) Arpeu
BE889708A (fr) Sous-soleuse
BE890439A (fr) Afdekbaanrol
FI810493L (fi) Foerflyttningselement
BE890703A (fr) Robinet-vanne
BE891654A (fr) Schuifdeur
BE888818A (fr) Telerupteur
BE887835A (fr) Fluidumsysteem
AR219450A1 (es) Portasachet
SE8004666L (sv) Sammanbindningsforfarande
BR8002740A (pt) Discomotor
BE891105A (nl) Kontinupers
DD157494A3 (de) Gleichstromkollonenboden
DD157517A3 (de) Peristaltikdosator

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: PFIZER INC.